Using proprietary nano-sized magnetic beads with specialized binding capabilities, Veravas, Inc., an early-stage diagnostics company based in Austin, Texas, has created a new development platform for biotech scientists. Researchers can employ it to measure antibodies against any antigen of interest in serum, plasma or saliva.